Increases in Bone Mineral Density After Discontinuation of Daily Human Parathyroid Hormone and Gonadotropin-Releasing Hormone Analog Administration in Women With Endometriosis

Joel S. Finkelstein, Amy Laura Arnold
In: Obstetrical & Gynecological Survey · 1999 · vol. 54(9) , pp. 575–577 · doi:10.1097/00006254-199909000-00019 · W2316806770
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Discontinuation of daily human parathyroid hormone and GnRH analog treatment in women with endometriosis resulted in increases in bone mineral density.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts J Clin Endocrinol Metab 1999;84:1214-1219

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK